Health Canada funds HIV/AIDS project

The Honourable Jacques Saada, Leader of the Government in the House of Commons and Minister responsible for Democratic Reform, and Mr. Guy St-Julien, M.P. for Abitibi-Baie-James-Nunavik, announced today, on behalf of the Honourable Pierre Pettigrew, Minister of Health, a contribution of $95,000 over two years to le Centre d'amitié autochtone de Val d'Or for an HIV/AIDS prevention program.

In Canada, it is estimated that every day one Aboriginal person becomes infected with HIV/AIDS. Partners in this project include le Centre de Santé Vallée-de-l'Or, la Régie Régionale de la santé et des services sociaux de l'Abitibi-Témiscamingue, le Service de Santé Kitcisasik, le Service de Santé Lac Simon, La clinique régionale VIH/sida and staff from MRC de la Vallée-de-l'Or.

The objectives of the project are: to increase awareness of the Aboriginal population of the resources and services for HIV/AIDS in the area, to increase awareness of risk behaviours, and to increase the number of Aboriginal people who have healthy lifestyles related to HIV/AIDS.

"This is two-year project will increase awareness of HIV/AIDS related services to Aboriginals throughout Val-d'Or," said Minister Saada. "It is designed to enhance the visibility and access to resources available to Aboriginal peoples infected with HIV/AIDS, and will feature HIV/AIDS prevention education to help stem the spread infections in the area."

"The project will provide culturally sensitive education," said Mr. St-Julien. "It will also help develop strategies that respond to the needs of Aboriginals living with HIV/AIDS, their families and communities."

"Canada has a collaborative approach to the fight against HIV/AIDS, which is carried out in partnership with other levels of government, non-governmental organizations and community organizations," said Minister Pettigrew. "This project is another example of how this integrated approach will help people infected with or at risk of HIV/AIDS."

The Government of Canada funding was provided to le Centre d'amitié autochtone de Val-d'Or under the Canadian Strategy for HIV/AIDS (CSHA). Since 1998, the Strategy has been providing stable, ongoing funding of $42.2 million annually to address the HIV/AIDS epidemic in Canada. The Strategy's goals are:

  • to prevent the spread of HIV infection in Canada;
  • to find a cure;
  • to find and provide effective vaccines, drugs and therapies;
  • to ensure care, treatment and support for Canadians living with HIV/AIDS, and for families, friends, and caregivers;
  • to minimize the adverse impact of HIV/AIDS on individuals and communities; and,
  • to minimize the impact of social and economic factors that increase individual and collective risk of HIV infection.

Of CSHA resources, $3.4 million is specifically targeted to Aboriginal communities. In addition, the Federal Government contributes $2.5 million for on-reserve HIV/AIDS programs administered by Health Canada's First Nations and Inuit Health Branch.

There are now more than 42 million people living with HIV/AIDS around the world, and over 3 million people died of AIDS-related illnesses in 2002. In Canada, about 4,000 people become infected with HIV despite prevention efforts.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus